Back to search

Article

Shuangshen Ningxin Capsule alleviates myocardial ischemia-reperfusion injury in miniature pigs by modulating mitophagy:network pharmacology and experiments in vivo

2023-06-12

Abstract excerpt

<title>Abstract</title> <p>Background:Myocardial ischemia/reperfusion injury (MI/RI) is a common pathological basis for several cardiovascular diseases, for which no effective treatment exists. Shuangshen Ningxin (SSNX) capsule which is developed by Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine has been demonstrated to alleviate MI/RI, but its mechanism remains to be further elucidated. <h4>Met...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
36d7bf46-9411-5e32-a383-6a102503da9c
DOI
10.21203/rs.3.rs-2996042/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Shuangshen Ningxin Capsule alleviates myocardial ischemia-reperfusion injury in miniature pigs by modulating mitophagy:network pharmacology and experiments in vivoDOI 10.21203/rs.3.rs-2996042/v1
Shenlian Extract in the Treatment of Ultrafine Particulate Matter- Aggravated Myocardial Ischemic Injury: Integrating Network Pharmacology and in vivo Pharmacological EvaluationSemantic proximity
Exploration of the molecular targets and mechanisms of suxiao xintong dropping pills for myocardial infarction by network pharmacology methodSemantic proximity
Integration of in vivo exposure and network pharmacology to investigate the pharmacodynamic material basis and action mechanism of Sinomenii Caulis in the treatment of myocardial infarctionSemantic proximity
Network Pharmacology to Explore Active Components and Pharmacological Mechanism of Action of Compound Longmai Ning Decoction for the Treatment of Myocardial InfarctionSemantic proximity
Integrated network pharmacology to investigate the mechanism of Salvia miltiorrhiza Bunge in the treatment of myocardial infarctionSemantic proximity
Network pharmacology exploration reveals the bioactive compounds and molecular mechanisms by which Gui-Qi-Yang-Xin Decoction suppresses myocardial fibrosisSemantic proximity
Research on the Mechanism of Wuwei Yuganzi San in the Treatment of Coronary Heart Disease Based on Network PharmacologySemantic proximity
Exploring the Pharmacological Mechanism of the modified Chinese medicine formulas “Shenfu-Linguizhugan decoction” treating Dilated cardiomyopathy Based on Network PharmacologySemantic proximity
Exploring key regulators involved in cardiac ischemic preconditioning through proteomic analysis in ischemia reperfusion mice modelsSemantic proximity
The study of neuroprotective effects and underlying mechanism of Naoshuantong capsule on ischemia stroke miceSemantic proximity
Intervention of Tanshinone IIA on the PGK1-PDHK1 Pathway to Reprogram Macrophage Phenotype After Myocardial Infarction.Semantic proximity
Integrating GEO Database and Bioinformatics Analysis to Screen the Key Targets of Tanshinone IIA in Myocardial InfarctionSemantic proximity
Select a neighboring publication to make it the new centre.